Dova Pharmaceuticals CFO Mark Hahn receives $5.1M in 2018

Dova Pharmaceuticals reports 2018 executive compensation

Published: March 15, 2019

Dova Pharmaceuticals reported fiscal year 2018 executive compensation information on March 15, 2019.

In 2018, four executives at Dova Pharmaceuticals received on average a compensation package of $2.8M, a 11% decrease compared to previous year.

Average pay of disclosed executives at Dova Pharmaceuticals

Mark W. Hahn, Chief Financial Officer, received $5.1M in total. 92.83% of Hahn's compensation, or $4.7M, was in option awards. Hahn also received $358.9K in salary and $7.4K in other compensation.

David S. Zaccardelli, Chief Executive Officer, received a compensation package of $4.4M. 88.34% of the compensation package, or $3.9M, was in option awards.

Kevin Laliberte, Senior Vice President, Product Development, earned $1.4M in 2018.

Alex Sapir, Chief Executive Officer, received $412.1K in 2018, which decreases by 93% compared to 2017.